Sort
82,697 grants matching “vaccine development”
Immunological characterization of rationally-designed vaccines against plague in mice and non-human primate models
$695,461Ashok K Chopra · University Of Texas Med Br Galveston · R01 · FY2022 · AI
ANIMAL RESOURCE IMPROVEMENT: YNPRC
$695,449Emory University · G20 · FY2003 · RR
IGF::OT::IGF RESEARCH, DEVELOPMENT, MANUFACTURE OF CLINICAL MATERIALS, AND CLINICAL TESTING OF VACCINES TO PROTECT AGAINST ZIKA VIRUS
$695,440Theresa Engel · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA
Dengue-Zika: Correlates of Cross-Protection in Non-Human Primates
$695,400Carlos A Sariol · University Of Puerto Rico Med Sciences · R01 · FY2021 · AI
Rational Design of antivrials targeted to HIV-1 capsid
$695,365Asim K Debnath · New York Blood Center · R01 · FY2012 · AI
NYC Transit Workers and COVID-19: Impact of Multilevel Interventions
$695,282Robyn R.m. Gershon · New York University · R01 · FY2023 · NR
Autism Spectrum Disorder: Birth Cohort 1976-2000, Epidemiology and Adult Status
$695,243Slavica K Katusic · Mayo Clinic Rochester · R01 · FY2015 · MH
Chlamydial Vaccine Testing in Mice and Guinea Pigs
$695,230Nilu Goonetilleke · Univ Of North Carolina Chapel Hill · U19 · FY2023 · AI
Prospective study of cutaneous viral infections and non-melanoma skin cancer
$695,218Dana Elise Rollison · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2014 · CA
Innate immune response of LTBI+HIV+ children
$695,140Ramakrishna Vankayalapati · University Of Texas Hlth Ctr At Tyler · R01 · FY2021 · AI
Innate immune response of LTBI+HIV+ children
$695,140Ramakrishna Vankayalapati · University Of Texas Hlth Ctr At Tyler · R01 · FY2022 · AI
Discovery of SARS-CoV-2 antivirals using a replicon assay
$695,135Stefan G Sarafianos · Emory University · R01 · FY2025 · AI
T Cell Memory to Pathogens: Generation and Function
$695,076Susan L Swain · Univ Of Massachusetts Med Sch Worcester · P01 · FY2011 · AI
Visceral Leishmanasis in Bihar State, Indian
$695,068Shyam Sundar · Banaras Hindu University · P50 · FY2011 · AI
A Multicomponent Anthrax Vaccine using Phage T4 Display
$695,043Catholic University Of America · U01 · FY2005 · AI
Clinical And Therapeutic Studies Of Human Filariasis and Related Diseases
$695,042Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$695,031William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Engineering CAR-B cells for an HIV-1 functional cure
$695,020Michael R. Farzan · University Of Florida · R01 · FY2022 · DA
Alaska Native Communities Advancing Vaccine Uptake
$694,994Julie Beans · Southcentral Foundation · R01 · FY2023 · AI
Mechanistic Studies of Combination Adjuvants to Target B Cells in Vaccines
$694,960Luc Teyton · Scripps Research Institute, The · U01 · FY2025 · AI
Developmental Exposures to Arsenic: Pneumonia, Immunity, and Microbiomes (DEAPIM)
$694,952Muhammad F Parvez · Columbia University Health Sciences · R01 · FY2025 · ES
Occurrence and Outcome of Dual HIV-1 Infection
$694,859James Ivan Mullins · University Of Washington · R37 · FY2010 · AI
The development of a recombinant vaccine against human onchocerciasis
$694,825Sara Lustigman · New York Blood Center · R01 · FY2018 · AI
Clinical
$694,806Paul A. Goepfert · University Of Alabama At Birmingham · P30 · FY2011 · AI
iLookOut for Child Abuse: Microlearning to Improve Knowledge Retention
$694,729Benjamin H. Levi · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2021 · HD